A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

NCT00231556 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Seizures
Epilepsies, Partial
Epilepsy, Generalized
Epilepsy, Tonic-Clonic

Interventions

DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.